Innovent Biologics Inc. ADR (IVBIY)
Market Closed
14 Oct, 08:00 PM
OTC PINK OTC PINK Primary $
54. 29
0
0%
$
23.67B Market Cap
- P/E Ratio
- Div Yield
60 Volume
0 Eps
$ 54.29
Previous Close Want to track IVBIY and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
China's Innovent Biologics gains commercialization rights for Eli Lilly breast cancer drug
Innovent Biologics has entered into an agreement that grants it sole commercialization rights for Eli Lilly's breast cancer drug Verzenios in mainland China, the Chinese drugmaker said Tuesday.
Reuters | 3 months ago
2026 © Marketlog. All Rights Reserved.
